Dihon

This page shows the latest Dihon news and features for those working in and with pharma, biotech and healthcare.

Bayer puts research at heart of business growth

This area has been boosted over the past year with the acquisition of Merck &Co's consumer health division and the takeover of China-based Dihon Pharmaceutical.

Latest news

Bayer completes takeover of Chinese OTC company

Bayer completes takeover of Chinese OTC company. Expands consumer health presence with Dihon purchase. ... Germany's Bayer has completed its acquisition of the China-based consumer healthcare company Dihon Pharmaceutical.
Pharma is turning its attention to consumer healthcare

The company also bought Chinese based Dihon Pharmaceuticals, which specialises in OTC medicines and traditional herbal remedies, to increase its offering and presence in Asia. “
Bayer raises sales predictions for new pharma products

Fresh from announcing a deal to buy Chinese over-the-counter drugmaker Dihon Pharmaceutical, Bayer also reported a 4 per cent sales decline for its consumer health division to 1.96bn - ... Consumer health should return to low- to mid-single-digit growth
Bayer buys Chinese consumer care company

Bayer buys Chinese consumer care company. Acquires Dihon Pharmaceutical as Algeta takeover closes. ... Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Sustainable solutions

This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editor – Medical Education Agency – Bucks: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Medical Writer, e-learning/ training, London: Excellent Salary

Project Manager, Medical Communications, Oxford: Excellent Salary

Senior Medical Writer: Great salary and benefits

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Project Manager, Medical Communications, London: Excellent Salary

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Account Manager or AD - Medical Communications: Salary TBC

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Account Manager / Account Director: Great salary and bebefits

Scientific Director: Great salary and bebefits

Account Manager – Med Comms – London: Salary TBC

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Senior Medical Writer: Great salary and bebefits

Editorial Director – Medical Education – Oxford: Negotiable

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...